Faulty swine flu vaccine withdrawn in Canada 24/11 19:11 CET
Influenza A (H1N1)world news.smaller_textlarger_textprint_articleBritish drugs giant GlaxoSmithKline has has warned the Canadian medical authorities that a batch of its anti-H1N1 vaccine can trigger potentially dangerous allergic reactions. The Canadians have withdrawn the batch from use and are testing it after it produced a range of serious reactions, notably in the heart and lungs. The recall affects 172,000 doses of the Arepanrix vaccine.
No comments:
Post a Comment